Talk:Sanofi: Difference between revisions
Content deleted Content added
| Line 36: | Line 36: | ||
---- |
---- |
||
:* According to [http://en.sanofi-aventis.com/group/presentation/p_group_presentation_keyfigures.asp Sanofi-Aventis figures], it is no. 1 in [[Europe]] and no. 3 worldwide in ''pharmaceutical industry''. Perhaps it's counting only certain revenues, since many companies are diversified. I think the claim of ''world's no. 3'' is verified by [http://www.usatoday.com/news/health/2004-11-09-superpill_x.htm this USA Today article], [http://www.forbes.com/business/energy/feeds/ap/2004/11/04/ap1635357.html this Forbes article], [http://story.news.yahoo.com/news?tmpl=story&cid=571&ncid=751&e=1&u=/nm/20041105/hl_nm/health_sanofi_acomplia_dc this Reuters article]. We'll '''keep''' the world claim and '''remove''' the [[Europe]] claim. How is that? --[[User:JM Robert|JM Robert]] 05:36, Dec 4, 2004 (UTC) |
:* According to [http://en.sanofi-aventis.com/group/presentation/p_group_presentation_keyfigures.asp Sanofi-Aventis figures], it is no. 1 in [[Europe]] and no. 3 worldwide in ''pharmaceutical industry''. Perhaps it's counting only certain revenues, since many companies are diversified. I think the claim of ''world's no. 3'' is verified by [http://www.usatoday.com/news/health/2004-11-09-superpill_x.htm this USA Today article], [http://www.forbes.com/business/energy/feeds/ap/2004/11/04/ap1635357.html this Forbes article], [http://story.news.yahoo.com/news?tmpl=story&cid=571&ncid=751&e=1&u=/nm/20041105/hl_nm/health_sanofi_acomplia_dc this Reuters article]. We'll '''keep''' the world claim and '''remove''' the [[Europe]] claim. How is that? --[[User:JM Robert|JM Robert]] 05:36, Dec 4, 2004 (UTC) |
||
**"Perhaps it's counting only certain revenues". That sounds probable in that case. But what revenues? Just drugs? The "pharmaceutical companies" category has all the drug companies from both [http://biz.yahoo.com/p/majrrxmktd.html Major Drugs] and [http://biz.yahoo.com/p/biotrxmktd.html Biotechnology & Drugs]. In the Biotech category it's number two behind [[Amgen]] - [[User:Jerryseinfeld|Jerryseinfeld]] 15:09, 4 Dec 2004 (UTC) |
**"Perhaps it's counting only certain revenues". That sounds probable in that case. But what revenues? Just drugs? The "pharmaceutical companies" category has all the drug companies from both [http://biz.yahoo.com/p/majrrxmktd.html Major Drugs] and [http://biz.yahoo.com/p/biotrxmktd.html Biotechnology & Drugs]. In the Biotech category it's number two by [[market cap]] behind [[Amgen]]. - [[User:Jerryseinfeld|Jerryseinfeld]] 15:09, 4 Dec 2004 (UTC) |
||
Revision as of 15:15, 4 December 2004
Manual of Style
Jerryseinfeld, please consult Wikipedia:Manual of Style before editing.
- Place external link in the External Links section. Consult Wikipedia:Don't use external links where we'll want Wikipedia links.
- Do not make links if words are linked previously. Consult Wikipedia:Manual of Style.
--JamesTseng 20:45, Nov 13, 2004 (UTC)
- I removed the double link on L'Oreal, are you satisfied? - Jerryseinfeld 22:35, 13 Nov 2004 (UTC)
- To clarify, please place external links such as SNY in External Links section.
- Also, please do not make double link, such as Paris and France in History section. They have been linked in the introduction already.
- --JamesTseng 06:06, Nov 14, 2004 (UTC)
- Okay, I give up. - Jerryseinfeld 14:31, 14 Nov 2004 (UTC)
Stockholders
The information provided about Stockholders is excellent! I'm just linking the common terms to their proper accounting terms. No intent to discredit the original contributor! --JM Robert 23:55, Nov 25, 2004 (UTC)
Vandalism?
This was pretty funny, 80.177.155.23 writes "Deleted "and Europe's #1 pharma company" - GSK is both European-headquartered and bigger both by revenues & market capitalisation" then JM Robert writes "Rv to JM Robert edit. Vandalism by 80.177.155.23". In reality the company is europe's 3rd largest, and the worlds ?th largest. - Jerryseinfeld 03:09, 4 Dec 2004 (UTC)
December, 2004 (revenue from fiscal year 2003)
- Sanofi-Aventis
- Revenue: 10118.00 M
- Market cap: 55.65B
- GlaxoSmithKline
- Revenue: 38238.00 M
- Market cap: 127.23B
- AstraZeneca
- Revenue: 18849.00 M
- Market cap: 68.19B
- Pfizer
- Revenue: 45188.00 M
- Market cap: 210.04B
- According to Sanofi-Aventis figures, it is no. 1 in Europe and no. 3 worldwide in pharmaceutical industry. Perhaps it's counting only certain revenues, since many companies are diversified. I think the claim of world's no. 3 is verified by this USA Today article, this Forbes article, this Reuters article. We'll keep the world claim and remove the Europe claim. How is that? --JM Robert 05:36, Dec 4, 2004 (UTC)
- "Perhaps it's counting only certain revenues". That sounds probable in that case. But what revenues? Just drugs? The "pharmaceutical companies" category has all the drug companies from both Major Drugs and Biotechnology & Drugs. In the Biotech category it's number two by market cap behind Amgen. - Jerryseinfeld 15:09, 4 Dec 2004 (UTC)